Chief of Staff to CEO of BridgeBio and GondolaBio

Responsibilities

• The Chief of Staff should be:
• Patient-focused
• A clear and structured communicator who distills complexity into concise insights and recommendations
• Comfortable operating in ambiguity and able to create clarity where none exists
• Influential without formal authority, able to align senior stakeholders and drive follow-through
• Detail-oriented but never lose sight of enterprise-level priorities
• Biased toward action, with a strong sense of ownership and accountability
• Resilient and adaptable, able to shift gears quickly as priorities evolve
• Ensure cross-functional alignment and harmonization of strategy with operational activities across commercial launches, clinical programs, and new R&D
• Organize and interpret incoming data and discuss findings of relevant strategic analyses with senior leadership and relevant external stakeholders
• Help define / lead strategic initiatives (e.g., evaluate new scientific and information technologies, incubate new Affiliates or other ventures, and reduce rate-limiting steps in clinical development)
• Conduct weekly reviews of literature associated with ongoing and new programs of interest
• Manage key meetings with Board members and other senior leaders

Benefits

Additional Information

Mavericks Wanted When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on In 2015, we pioneered a "moneyball for biotech" approach, pooling projects and promising early-stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. We build bridges to groundbreaking advancements in rare disease, and develop life-changing medicines for patients with unmet needs as fast as humanly possible. Together we define white space, push boundaries, and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we'll ask "why not?" and help reengineer the future of biopharma. At BridgeBio, we value curiosity and experimentation-including the ethical & thoughtful use of AI to improve clarity, speed, and quality of work. BridgeBio is a commercial stage biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases. We bridge the gap between remarkable advancements in genetic science in academic institutions and the delivery of meaningful medicines to patients. Founded in 2015, the company has built a portfolio of 30+ drug development programs ranging from preclinical to late-stage development in multiple therapeutic areas including genetic dermatology, precision oncology, cardiology, endocrinology, neurology, pulmonology, and renal disease, with three approved drugs and three additional positive Phase 3 results, making the company one of the most productive R&D engines in the industry's history. To learn more about our story and company culture, visit us at https://bridgebio.com GondolaBio is a clinical-stage biopharmaceutical company focused on developing next-generation therapeutics for genetic diseases. A sister company of BridgeBio, GondolaBio secured $300M in private financing from external investors in August 2024. The company aims to leverage cutting-edge biological research to create breakthrough medicines addressing high unmet needs across multiple therapeutic areas in monogenic rare diseases. Located on the Stanford Life Sciences campus, GondolaBio fosters a unique hybrid environment where top scientists from around the world collaborate with senior leadership and advisors, blending industry expertise with academic innovation.

Your Match

How well this role fits your profile.

Company Intel

What employees say

Worked at bridgebio? Share your experience